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Redo Bypass Surgery to the Infrapopliteal Arteries
for Critical Leg Ischaemia
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Objectives: to evaluate the results of redo bypass surgery to the infrapopliteal artery and the value of adjuvant
arteriovenous fistula (AVF) in this setting.
Design: retrospective study.
Materials: fifty-one redo reconstructions to the infrapopliteal arteries were done for critical leg ischaemia in 45 patients
who have had primary infrainguinal reconstructions to the popliteal artery in 20 cases (39%), the crural arteries in 18
(35%), and the pedal arteries in 13 (25%).
Methods: a PTFE prosthesis was used in 21 cases (41%). A Miller cuff was used in 16 prosthetic grafts. Adjuvant AVF
was added to three autogenous vein and 12 prosthetic grafts.
Results: at 2 years, the primary patency rate was 42%, the secondary patency was 43%, the limb salvage was 67%, the
survival was 77%, and 53% of patients were alive with salvaged leg. The primary patency rate with a vein graft was
44% at 1 year, with prosthesis plus AVF 67%, but with prosthesis without AVF only 19%. Secondary patency rates
were similar. Prosthetic graft with AVF and those without AVF achieved a 1-year leg salvage rate of 100% and 51%,
respectively (p=0.01). Patients with adjuvant AVF had a worse 2-year survival rate that those without AVF (31% vs
89%) (p=0.007; RR: 8.87, CI 95%: 1.62–48.42).
Conclusions: redo bypass surgery using autogenous vein graft may achieve satisfactory long-term results. The use of
adjuvant AVF may improve patency of redo infrapopliteal prosthetic bypass grafts.
Key Words: Vascular surgery; Critical leg ischaemia; Infrainguinal; Infrapopliteal; Secondary; Redo; Reoperation; Graft
occlusion; Adjuvant arteriovenous fistula.
Introduction failure (of more than 4 weeks’ duration) resulting in
recurrent CLI31 (Table 2).
Many patients require redo vascular and endovascular The primary choice of graft material was an auto-
induction for failing and failed infrapopliteal grafts.1–4 genous vein and only secondarily a PTFE in cases
However, the indications for, and results of, re-inter- where no proper vein was available. Apart from the
vention are highly variable and controversial.5–17 (Table beginning of the study period the standard procedure
1). in our unit in case of a crural recontruction with PTFE
In the present study we report the results of a as graft material is to apply an outflow vein-cuff, i.e.
retrospective analysis of our experience in redo bypass a Miller cuff. The mean period to failure of the first
grafting to the infrapopliteal arteries for critical leg bypass graft was 20 months (range, 1–145 months).
ischaemia (CLI) after late failure of an infrainguinal Forty-three reconstructions (84%) were carried out
bypass graft and, in particular, the results of re- more than 3 months, and 17 reconstructions (33%)
operative bypass surgery with the use of adjuvant more than 1 year, after the primary procedure.
arteriovenous fistula (AVF). The primary bypass had been to the popliteal artery
in 20 cases (39%), the crural arteries in 18 (35%), and
Material and Methods the pedal arteries in 13 (25%).
Redo bypass surgery was carried out to the same
Between 1991 and 1999 45 patients underwent 51 redo outflow artery of primary procedure in 16 cases (29%).
bypasses to the infrapopliteal arteries because of graft A PTFE prosthesis was used in 21 cases (41%) (two
cases of composite PTFE-autogenous vein) and an
∗ Please address all correspondence to: M. Railo, Department of autogenous vein graft in 30 cases (59%). ContralateralVascular Surgery, Helsinki University Central Hospital, PO Box 340,
00029 HUS, Finland. saphenous vein was available in 10 cases (18%), an
1078–5884/01/020137+06 $35.00/0  2001 Harcourt Publishers Ltd.
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Table 2. Clinical data of patients who underwent redo infra- The Cox regression model with the help of backward
popliteal bypass surgery. selection was used to estimate the impact of variables
No. of patients/procedures 45/51 on the clinical outcome. A p-value less than 0.05 was
Sex M/F 27/18 considered a statistically significant difference.
Mean age (range) 71.8 (51–92)
Status of the leg
Rest pain 22 (43%)
Foot ulcer 27 (53%)
Foot gangrene 2 (4%) ResultsDiabetes 24 (47%)
Hypertensiona 28 (55%)
Coronary artery disease 32 (63%) Three patients (6%) died within 30 days. Seven patients
Cerebrovascular disease 8 (16%) suffered postoperative cardiac events (14%) and threeChronic renal failureb 4 (8%)
patients had respiratory complications (6%).Inflow artery of redo operation
Common iliac artery 1 (2%) At 1 month, 1 year and 2 years, the primary patency
External iliac artery 1 (2%) rates were 88%, 45% and 42%, the secondary patencyCommon femoral artery 33 (65%)
rates were 90%, 52% and 43%, the leg salvage ratesDeep femoral artery 4 (8%)
Superficial femoral artery 3 (6%) were 94%, 74% and 67%, the survival rates were 94%,
Above-knee popliteal artery 2 (4%) 94% and 77%, and 88%, 69% and 53% of patients wereBelow-knee popliteal artery 5 (10%)
alive with salvaged leg.Arterial graft 2 (4%)
Ouflow artery of redo operation Univariate and multivariate analysis showed that
Tibioperoneal trunk 4 (8%) both primary patency (p=0.04; p=0.05) and secondaryAnterior tibial artery 10 (20%)
patency (p=0.02; p=0.05) outcomes were affected byPosterior tibial artery 9 (18%)
Peroneal artery 13 (25%) the type of arterial reconstruction (Fig. 1). At 1-year
Pedal arteries 14 (27%) follow-up, the primary patency rates after redo bypassDistal anastomotic part of the previous graft 1 (2%)
surgery with a vein graft was 44%, after surgery
a: blood pressure >160/95 mmHg or antihypertensive medication; with prosthesis plus AVF 67% and after surgery using
b: serum level of creatinine >150 mol/l. prosthesis without AVF 19%. Secondary patency rates
were similar to these figures. Autogenous saphenous
vein grafts did not achieve significantly different pat-arm vein was used in 17 cases (33%), a combination
of segments of autogenous veins in three cases (6%) ency rates than arm vein grafts.
At 1-year follow-up, prosthetic bypasses with AVF(Table 3). A Miller cuff was used in 16 prosthetic grafts.
A common ostium AVF or proximal AVF was added seemed to achieve a better leg salvage rate than the
other grafts, but the difference did not reach statisticalto three autogenous vein grafts and to 12 prosthetic
grafts. To evaluate the equivalence of the patients in significance (p=0.1) (Fig. 2). Prosthetic graft with AVF
and prosthesis without AVF achieved a 1-year legthe different groups (PTFE with AVF, PTFE without
AVF and autogenous vein) the run-off scores according salvage of 100% and 51%, respectively (p=0.01).
There were 11 patients lost to follow-up, six of themto the angiograms in the different groups were evalu-
ated. The median run-off score for the group of patients had a follow-up time less than 4 months and five of
them had a follow-up time from 4 to 10 months. Fourwith autogenous vein as graft material was 4.5 and
5.0 for those with PTFE grafts. Median run-off score patients had a PTFE reconstruction and two of them
had an AVF and a Miller cuff. Seven patients were infor AVF and no AVF was 5.0 and 4.5, respectively, and
5.0 for those reconstructions with a Miller cuff and 4.5 the vein group, three of them had a follow-up time
between 5 and 9.3 months.for those without. The graft patency was assessed 3-
monthly during the first year and 6-monthly thereafter. Univariate analysis showed that survival rate dif-
fered with the type of arterial reconstruction per-Graft and AVF patency was determined by physical
examination, ankle/brachial index measurements and, formed, i.e. vein grafts, prostheses without AVF and
prostheses with AVF (p=0.003) (Fig. 3). Univariatewhen indicated, by duplex ultrasonography and angio-
graphy.32 and multivariate analysis showed that patients who
had an AVF had a worse 2-year survival rate thanData were statistically analysed with the use of a
microcomputer database (SPSS for Windows 7.5, SPSS those without this adjuvant technique (31% vs 89%)
(p=0.003; p=0.007; RR: 9, CI 95%: 1.6–48).Inc., 444 North Michigan Avenue, Chicago, IL 60611,
U.S.A.). The Kaplan–Meier method with the log-rank Among patients with prosthetic graft, those with
adjuvant AVF had a 2-year rate of patients alive withtest was used to estimate graft patency, leg salvage,
survival and the rate of patients alive with salvaged salvaged leg of 22%, whereas the corresponding figure
for those without AVF was 65% (NS).leg and to compare the outcome of different subgroups.
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Table 3. Clinical data on primary and redo-outflow and graft material. Number of patients with AV fistula in brackets.
Primary outflow n Redo-outflow n Graft material Controlat. Armvein
PTFE VSM
Distal popliteal 20 Fibular 7 3 (2) 2 2
Post. tibial 5 3(3) 2
Ant. tibial 3 2 1
Pedal 3 1 1 1 (1)
Tib.-per. trunc 2 2
Tib.-Per. trunc 1 Post. tibial 1 1 (1)
Ant. Tibial 8 Ant. tibial 3 1 (1) 1 1
Fibular 1 1 (1)
Tib.-per. trunc 2 2
Pedal 2 2
Post. Tibial 4 Ant. tibial 1 1 (1)
Post tibial 1 1
Fibular 1 1
Pedal 1 1
Fibular 5 Fibular 3 1 (1) 2
Ant. tibial 1 1
Post. tibial 1 1
Pedal 13 Pedal 9 1 5 (1) 3 (1)
Ant. tibial 2 1 (1) 1
Fibular 1 1 (1)
Post. tibial 1 1
In total 21 (12) 10 (1) 20 (2)
Fig. 2. Leg salvage outcome in the subgroups of patients who
underwent redo bypass grafting with vein grafts (⊥), prosthesis
Fig. 1. Primary patency outcome in the subgroups of patients who without AVF (69) and prosthesis with AVF (—) (p=0.1).
underwent redo bypass grafting with vein grafts (⊥), prosthesis
without AVF (69) and prosthesis with AVF (—) (log rank: p=0.04).
not considered suitable for these procedures, due to a
lengthy occlusion time.Discussion
Redo bypass surgery with autogenous conduits
has been shown to achieve satisfactory long-termThrombectomy and thrombolysis, with or without
graft revision, are therapeutic options in case of infra- results.5,13,14,40 Edwards et al.14 achieved good long-
term results with the use of autogenous vein conduitsinguinal bypass graft failure.33–40
However, the series comprises of patients who were reporting a primary patency rate of 57%, a secondary
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of bypass grafting procedures were done in patients
with a history of a previous ipsilateral bypass pro-
cedure, but the authors did not analyse the outcome
of this subgroup according to the distal anastomotic
technique.44
Two recent series17,45 did not reveal any potential
benefit of AVF in femorocrural bypass grafting with
PTFE plus distal vein cuff. Indeed, in the series by
Wijesinghe et al.,17 patients with AVF had lower limb
salvage rates. However, this study included 23 sec-
ondary grafts (45%) and four tertiary grafts (8%) and
an AVF was added only in patients with an incomplete
pedal arch as shown on preoperative angiogram. No
analysis of the results in this subgroup of patients
with repeat bypass grafts has been presented and it is
likely that this could affect the conclusions on the
efficacy of AVF.17
This present series shows an improvement in pros-
thetic bypass graft patency and limb salvage with the
use of adjuvant AVF. This raises the question as to
whether the results of vein grafts could be improvedFig. 3. Survival outcome in the subgroups of patients who underwent
redo bypass grafting with vein grafts (⊥), prostheses without AVF by adding an adjuvant AVF. However, the survival
(69) and prostheses with AVF (—) (log rank: p=0.003). analysis showed a marked reduction in long-term
survival in patients with an adjuvant AVF. This may
patency rate of 71% and a leg salvage rate of 90% at 5- be due to more severe conditions of these patients. In
year follow-up. The same group reported good results fact, most of the events occurred in the early post-
with redo bypass surgery even after multiple failures operative period (Fig. 3). However, we are unable to
of infrainguinal bypass grafts.5 exclude any adverse impact of AVF on cardiac function
Unfortunately, most of these patients do not have a as previously seen in one of our patients.46
suitable vein and surgeons are forced to use a pros- In conclusion, autogenous conduits may achieve
thetic graft despite their poor patency.11,12,30 satisfactory long-term results both in terms of graft
In order to improve the results, vein cuffs and patency, leg salvage and survival. Revascularisation
patches41,42 are often used although they have not been of critically ischaemic legs after late occlusion of a
reported to improve secondary infrainguinal re- previous infrainguinal bypass graft in absence of auto-
vascularisations.11 genous graft material is likely to achieve poor results.
Adjuvant AVF has been used to increase graft blood AVF added to a redo prosthetic bypass grafting was
flow by increasing outflow,43 but the results are still shown to improve graft patency and leg salvage out-
controversial.30,44 come, but the observation of poorer survival outcome
In a study including both primary and secondary raises questions about its potentially adverse impact
bypass grafts to the infrageniculate arteries, Jakobsen on cardiac function.
et al.30 did not find any statistically significant dif-
ference in patency rates between prosthetic graft with
Miller cuff vs Wolfe cuff plus AVF; the 1-year patency
rates being 59% and 67%, respectively, and 2-year
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